Home page  |  Help  |  Clear
English  |  French
 Search  |  Categories  |  Titles A-Z  |  Countries  |  Compare countries  |  Index  
Full TOC
Expand Document
Expand Chapter
Preferences

close this bookStandard Treatment Guidelines for Health Station - Ethiopia (DACA; 2002; 124 pages)
View the documentFOREWORD
View the documentACKNOWLEDGEMENTS
View the documentINTRODUCTION
View the documentGENERAL GUIDANCE
View the documentHOW TO USE THIS STANDARD TREATMENT GUIDELINE
Open this folder and view contentsChapter 1: INFECTIONS DISEASES
Open this folder and view contentsChapter 2: SEXUALLY TRANSMITTED DISEASES
Open this folder and view contentsChapter 3: COMMON SKIN PROBLEMS
close this folderChapter 4: NON-INFECTIOUS DISEASES
View the documentANEMIA
View the documentANXIETY DISORDER
View the documentBRONCHIAL ASTHMA
View the documentCONSTIPATION
View the documentEPILEPSY
View the documentHEMORRHOIDS
View the documentMIGRAINE
View the documentNAUSEA AND VOMITING
View the documentNON-ULCER DYSPEPSIA
View the documentOSTEOARTHRITIS
View the documentRHEUMATOID ARTHRITIS
Open this folder and view contentsChapter 5: OBSTETRICS AND GYNECOLOGICAL CONDITIONS
Open this folder and view contentsChapter 6: PEDIATRIC DISEASES
Open this folder and view contentsChapter 7: ACUTE/EMERGENCY CONDITIONS
Open this folder and view contentsANNEXES
 

NON-ULCER DYSPEPSIA

Non-ulcer dyspepsia is a chronic, recurrent, often meal-related epigastric discomfort, pain or fullness. The location of the pain and the relationship to meals resembles the classic description of PUD except that no evidence for ulcer will be found by either endoscopy or barium studies.

Diagnosis is often made on clinical grounds but endoscopy or barium meal studies might be required to exclude ulcer.

Treatment

First line:

Mixtures of Aluminiumhydroxide and Magnesium trisilicate, 10 - 30 ml or

2 - 4 chewable tablets p.o. taken between meals prn.

S/E: rare and mild

C/I: insignificant

Dosage forms: suspension, 310 mg + 620 mg in 5 ml; tablet (chewable), 120 mg + 250 mg; 250 mg + 500 mg.

OR

Mixtures of Magnesium hydroxide and aluminium hydroxide, 10 - 30 ml or 2 - 4 chewable tablets, p.o. between meals prn.

Dosage forms: chewable tablet, 400mg + 400 mg, 195mg + 220mg in 5 ml.

OR

Magnesium trisilicate 2 - 4 chewable tablets, p.o. between meals prn.

Dosage forms: chewable tablet, 500 mg.

OR

Magnesium hydroxide, 10 - 30 ml or 2 - 4 chewable tablets, p.o. between meals PRN.

Dosage forms: chewable tablet, 300mg + 311mg; Mixture, 375mg/5ml, 7.75%.

to previous sectionto next section

Please provide your feedback English  |  French